Massive study tracks breast cancer care in china
NCT ID NCT07476170
First seen Mar 27, 2026 · Last updated May 12, 2026 · Updated 6 times
Summary
This study looks at how women with a common type of advanced breast cancer (HR+/HER2-) are treated in real-world clinics across China. Researchers will analyze medical records from 14,000 patients to see which treatments are used and how well they work. The goal is to fill gaps in knowledge, especially about newer drugs like CDK4/6 inhibitors, to improve future care.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HR+/HER2- ADVANCED OR METASTATIC BREAST CANCER are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Locations
-
Novartis Investigative SIte
RECRUITINGBingjie, Beijing Municipality, 100021, China
Conditions
Explore the condition pages connected to this study.